1Harrison DG,OharaY.Physiologic Consequences of Increased Vascular Oxidant Stresses in Hypercholeslerolemiaand Atherosclerosis:Implication for Impaired Vasomotion[J].Am JCardiol,1995,75(1):75B-87 B.
2Anderson TJ,Meredith IT,Yeung AG,et al.Efficacy of Pamidronate in ReducingSkeletal Events in Patients with Advanced Multiple Myeloma[J].N Engl JMed,1995,332(8):488-497.
3Kuga T,Egashira K,Mohri M,et al.Bradykinin-Induced Vasodilation is Impaired at theAtherosclerotic Site but is Preserved at the Spastic Site of Human Coronary Arteries InVivo[J].Circulation,1995,92(2):183-199.
5Langford EJ,Wainwright RJ,Martin JE.Platelet Activation in Acute MyocardialInfarction and Unstable Angina is Inhibited by Nitric Oxide Donors.Arteriosclerosis[J].Thrombosisand Vascular Biology,1996,16(1):51-55.
8Allan M,Lefer,David J,Lefer.Therapeutic role of nitric oxide donors in thetreatment of cardiovascular disease[J].Drugs of the Futare,1996,19(7):665-672.
9Joseph AL,William HF.Nitric oxide donors in the treatment of cardiovascular andpulmonary diseases[J].Am Heart J,1995,129(3):604-616.
10Pabla R,Curtis MJ.Effects of NO Modulation on Cardiac Arrhythmias in the RatIsolated Heart[J].Circulation Research,1995,77(5):984-992.
